Curaleaf Holdings (CURLF) EPS (Basic) Growth (3y) (2022 - 2026)
Curaleaf Holdings (CURLF) EPS (Basic) Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 15.17% |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 3.18% |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 2.42% |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 12.25% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -35.06% |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 13.47% |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 36.60% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Curaleaf Holdings | 2.48 Bn | 2.38 Bn | 169.91 Mn | 53.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.22% |
| Mar 31, 2026 | 72.17% |
| Dec 31, 2025 | 44.69% |
| Sep 30, 2025 | 46.19% |
| Jun 30, 2025 | 14.48% |
| Mar 31, 2025 | -34.88% |
| Dec 31, 2024 | -26.70% |
| Sep 30, 2024 | -71.19% |
| Jun 30, 2024 | -26.32% |
| Mar 31, 2024 | -77.58% |
| Dec 31, 2023 | -409.80% |
| Sep 30, 2023 | -40.65% |
| Jun 30, 2023 | -30.69% |
| Mar 31, 2023 | -44.99% |
| Dec 31, 2022 | -162.73% |
| Sep 30, 2022 | -67.10% |